Nataša Tozon

1.4k citations
54 papers · 963 indexed · h-index 19

Nataša Tozon

50 papers receiving 926 citations

Peers

Nataša Tozon
Comparison fields: 5 of 81
  • Biotechnology 553
  • Biomedical Engineering 245
  • Immunology 218
  • Molecular Biology 189
  • Genetics 183
Replace Robin Ruuls with:
Robin Ruuls Netherlands
Jürgen Hess Germany
Jean‐Marc Balloul France
Annette Kolb‐Mäurer Germany
Claudia Gravekamp United States
Michael D. Macklin United States
Drew Hannaman United States
Viet Khong Nguyen Belgium
Holger Loessner Germany
Jeong‐Im Sin South Korea
Nataša Tozon relative to Robin Ruuls Netherlands Robin Ruuls's profile →
Citations per field
00.5×6.0×
Robin Ruuls · 1×
Citations per year

Countries citing papers authored by Nataša Tozon

Since Specialization
Citations

This map shows the geographic impact of Nataša Tozon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nataša Tozon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nataša Tozon more than expected).

Fields of papers citing papers by Nataša Tozon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nataša Tozon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nataša Tozon. The network helps show where Nataša Tozon may publish in the future.

Co-authorship network of co-authors of Nataša Tozon

This figure shows the co-authorship network connecting the top 25 collaborators of Nataša Tozon. A scholar is included among the top collaborators of Nataša Tozon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nataša Tozon. Nataša Tozon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 6
4 14
5 0
6 4
7 14
8 7
9 3
10 7
11 7
12 25
13 10
14 12
15 9
16 9
17 86
18
Canine lymphoma: cytologic study and response to therapy.
0
19 14
20
Proteinuria in clinical diagnostic of renal disease in cats infected with feline immunodeficiency virus.
1

About Nataša Tozon

Nataša Tozon is a scholar working on Biotechnology, Small Animals and Virology, having authored 54 papers that have together received 963 indexed citations. Recurring topics across this work include Microbial Inactivation Methods (26 papers), Veterinary Oncology Research (12 papers) and Virus-based gene therapy research (10 papers). The work is most often cited by research in Biotechnology (553 citations), Parasitology (135 citations) and Small Animals (126 citations). Nataša Tozon has collaborated with scholars based in Slovenia, United States and Italy. Frequent co-authors include Maja Čemažar, Gregor Serša, Darja Pavlin, Urša Lampreht Tratar, Tatjana Avšič‐Županc, Justin Teissié, Miroslav Petrovec, A. Pogačnik, Alessandro Poli and Darja Duh. Their work appears in journals such as Annals of the New York Academy of Sciences, Clinical Microbiology and Infection and The Journal of Membrane Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026